Treggiari-Venzi M, Schiffer E R, Romand J A, Licker M, Morel D R
Department of Anaesthesia, Pharmacology and Surgical Intensive Care, University Hospital of Geneva.
Schweiz Med Wochenschr. 2000 Apr 29;130(17):608-16.
The influence of endothelium-dependent vasodilatation in regulating the hepatic circulation has been investigated by intraportal infusion of inhibitors of either endothelium-derived relaxing factor (NG-nitro-L-arginine-methyl-ester [L-NAME]) or of endothelium-derived hyperpolarising factor (ATP-dependent K(+)-channel inhibitor, glybenclamide) in barbiturate anaesthetised miniature pigs. Intraportal infusion of acetylcholine (5.5 micrograms kg-1 min-1 over 2 min) produced a selective 3-fold increase in hepatic artery and coeliac trunk blood flow, while mesenteric, portal, systemic, and pulmonary vascular beds remained unchanged. Intraportal L-NAME or glybenclamide did not reduce the hepatic artery and coeliac trunk flows but increased systemic and mesenteric vascular resistances. The acetylcholine-induced hepatic artery vasodilatation was partially blocked by 59%, 76% and 66% by L-NAME, at 30, 100, and 300 mg/kg respectively. Glybenclamide pretreatment up to 3 mg/kg did not modify acetylcholine-induced vasodilatation of the hepatic artery and coeliac trunk. Furthermore, prior cyclooxygenase inhibition did not alter the hepatic vascular response to acetylcholine. These results suggest that, in contrast to what is observed in large vessels, the hepatic vascular tree may not be entirely regulated by nitric oxide under basal conditions, but nitric oxide is released readily upon stimulation with acetylcholine, a response that is largely but incompletely blocked by L-NAME pretreatment. Neither basal vascular tone nor acetylcholine-induced vasorelaxation are mediated by the opening of glybenclamide-sensitive K+ channels in the hepatic circulation in pigs.
通过向巴比妥麻醉的小型猪门静脉内输注内皮源性舒张因子抑制剂(NG-硝基-L-精氨酸甲酯[L-NAME])或内皮源性超极化因子抑制剂(ATP依赖性钾通道抑制剂,格列本脲),研究了内皮依赖性血管舒张在调节肝循环中的作用。门静脉内输注乙酰胆碱(2分钟内5.5微克/千克·分钟)使肝动脉和腹腔干血流量选择性增加3倍,而肠系膜、门静脉、全身和肺血管床保持不变。门静脉内输注L-NAME或格列本脲并未降低肝动脉和腹腔干血流量,但增加了全身和肠系膜血管阻力。L-NAME分别以30、100和300毫克/千克的剂量部分阻断了乙酰胆碱诱导的肝动脉舒张,阻断率分别为59%、76%和66%。高达3毫克/千克的格列本脲预处理并未改变乙酰胆碱诱导的肝动脉和腹腔干舒张。此外,预先抑制环氧化酶并未改变肝脏对乙酰胆碱的血管反应。这些结果表明,与在大血管中观察到的情况相反,在基础条件下,肝血管树可能并非完全由一氧化氮调节,但在乙酰胆碱刺激下一氧化氮会迅速释放,L-NAME预处理可在很大程度上但不完全阻断这种反应。在猪的肝循环中,基础血管张力和乙酰胆碱诱导的血管舒张均不是由格列本脲敏感的钾通道开放介导的。